HIV-1 Neutralizing Antibodies with Limited Hypermutation from an Infant

Cell

Volumn 166, Issue 1, 2016, Pages 77-87

  Simonich, Cassandra A ^a,b   Williams, Katherine L ^a   Verkerke, Hans P ^c   Williams, James A ^c   Nduati, Ruth ^d   Lee, Kelly K ^c   Overbaugh, Julie ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF NAIROBI   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; NEUTRALIZING ANTIBODY; GLYCOPROTEIN GP 120; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ANTIGEN BINDING; ARTICLE; CASE REPORT; EPITOPE MAPPING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INDEL MUTATION; INFANT; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SOMATIC HYPERMUTATION; VIRUS ENVELOPE; VIRUS NEUTRALIZATION; VIRUS TRANSMISSION; ADULT; BLOOD; CLINICAL TRIAL; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; MONONUCLEAR CELL;

ADULT; ANTIBODIES, NEUTRALIZING; EPITOPES; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HUMANS; INFANT; LEUKOCYTES, MONONUCLEAR; SOMATIC HYPERMUTATION, IMMUNOGLOBULIN;

EID: 84976608123     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2016.05.055     Document Type: Article

References (61)

1. Benson, D.A., Karsch-Mizrachi, I., Lipman, D.J., Ostell, J., Wheeler, D.L., GenBank. Nucleic Acids Res. 33 (2005), D34–D38.
2. Burton, D.R., Mascola, J.R., Antibody responses to envelope glycoproteins in HIV-1 infection. Nat. Immunol. 16 (2015), 571–576.
3. Cortez, V., Wang, B., Dingens, A., Chen, M.M., Ronen, K., Georgiev, I.S., McClelland, R.S., Overbaugh, J., The broad neutralizing antibody responses after HIV-1 superinfection are not dominated by antibodies directed to epitopes common in single infection. PLoS Pathog., 11, 2015, e1004973.
4. deCamp, A., Hraber, P., Bailer, R.T., Seaman, M.S., Ochsenbauer, C., Kappes, J., Gottardo, R., Edlefsen, P., Self, S., Tang, H., et al. Global panel of HIV-1 Env reference strains for standardized assessments of vaccine-elicited neutralizing antibodies. J. Virol. 88 (2014), 2489–2507.
5. Doria-Rose, N.A., Joyce, M.G., Strategies to guide the antibody affinity maturation process. Curr. Opin. Virol. 11 (2015), 137–147.
6. Doria-Rose, N.A., Schramm, C.A., Gorman, J., Moore, P.L., Bhiman, J.N., DeKosky, B.J., Ernandes, M.J., Georgiev, I.S., Kim, H.J., Pancera, M., et al., NISC Comparative Sequencing Program. Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies. Nature 509 (2014), 55–62.
7. Doria-Rose, N.A., Bhiman, J.N., Roark, R.S., Schramm, C.A., Gorman, J., Chuang, G.Y., Pancera, M., Cale, E.M., Ernandes, M.J., Louder, M.K., et al. New member of the V1V2-directed CAP256-VRC26 lineage that shows increased breadth and exceptional potency. J. Virol. 90 (2015), 76–91.
8. Eroshkin, A.M., LeBlanc, A., Weekes, D., Post, K., Li, Z., Rajput, A., Butera, S.T., Burton, D.R., Godzik, A., bNAber: database of broadly neutralizing HIV antibodies. Nucleic Acids Res. 42 (2014), D1133–D1139.
9. Falkowska, E., Le, K.M., Ramos, A., Doores, K.J., Lee, J.H., Blattner, C., Ramirez, A., Derking, R., van Gils, M.J., Liang, C.H., et al. Broadly neutralizing HIV antibodies define a glycan-dependent epitope on the prefusion conformation of gp41 on cleaved envelope trimers. Immunity 40 (2014), 657–668.
10. Fouts, T.R., Binley, J.M., Trkola, A., Robinson, J.E., Moore, J.P., Neutralization of the human immunodeficiency virus type 1 primary isolate JR-FL by human monoclonal antibodies correlates with antibody binding to the oligomeric form of the envelope glycoprotein complex. J. Virol. 71 (1997), 2779–2785.
11. Goo, L., Jalalian-Lechak, Z., Richardson, B.A., Overbaugh, J., A combination of broadly neutralizing HIV-1 monoclonal antibodies targeting distinct epitopes effectively neutralizes variants found in early infection. J. Virol. 86 (2012), 10857–10861.
12. Goo, L., Milligan, C., Simonich, C.A., Nduati, R., Overbaugh, J., Neutralizing antibody escape during HIV-1 mother-to-child transmission involves conformational masking of distal epitopes in envelope. J. Virol. 86 (2012), 9566–9582.
13. Goo, L., Chohan, V., Nduati, R., Overbaugh, J., Early development of broadly neutralizing antibodies in HIV-1-infected infants. Nat. Med. 20 (2014), 655–658.
14. Guindon, S., Dufayard, J.F., Lefort, V., Anisimova, M., Hordijk, W., Gascuel, O., New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. Syst. Biol. 59 (2010), 307–321.
15. Haigwood, N.L., Montefiori, D.C., Sutton, W.F., McClure, J., Watson, A.J., Voss, G., Hirsch, V.M., Richardson, B.A., Letvin, N.L., Hu, S.L., Johnson, P.R., Passive immunotherapy in simian immunodeficiency virus-infected macaques accelerates the development of neutralizing antibodies. J. Virol. 78 (2004), 5983–5995.
16. Hoot, S., McGuire, A.T., Cohen, K.W., Strong, R.K., Hangartner, L., Klein, F., Diskin, R., Scheid, J.F., Sather, D.N., Burton, D.R., Stamatatos, L., Recombinant HIV envelope proteins fail to engage germline versions of anti-CD4bs bNAbs. PLoS Pathog., 9, 2013, e1003106.
17. Huang, J., Doria-Rose, N.A., Longo, N.S., Laub, L., Lin, C.L., Turk, E., Kang, B.H., Migueles, S.A., Bailer, R.T., Mascola, J.R., Connors, M., Isolation of human monoclonal antibodies from peripheral blood B cells. Nat. Protoc. 8 (2013), 1907–1915.
18. Jardine, J.G., Ota, T., Sok, D., Pauthner, M., Kulp, D.W., Kalyuzhniy, O., Skog, P.D., Thinnes, T.C., Bhullar, D., Briney, B., et al. HIV-1 VACCINES. Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen. Science 349 (2015), 156–161.
19. Kepler, T.B., Liao, H.X., Alam, S.M., Bhaskarabhatla, R., Zhang, R., Yandava, C., Stewart, S., Anasti, K., Kelsoe, G., Parks, R., et al. Immunoglobulin gene insertions and deletions in the affinity maturation of HIV-1 broadly reactive neutralizing antibodies. Cell Host Microbe 16 (2014), 304–313.
20. Klein, F., Diskin, R., Scheid, J.F., Gaebler, C., Mouquet, H., Georgiev, I.S., Pancera, M., Zhou, T., Incesu, R.B., Fu, B.Z., et al. Somatic mutations of the immunoglobulin framework are generally required for broad and potent HIV-1 neutralization. Cell 153 (2013), 126–138.
21. Klein, F., Mouquet, H., Dosenovic, P., Scheid, J.F., Scharf, L., Nussenzweig, M.C., Antibodies in HIV-1 vaccine development and therapy. Science 341 (2013), 1199–1204.
22. Kong, L., Lee, J.H., Doores, K.J., Murin, C.D., Julien, J.P., McBride, R., Liu, Y., Marozsan, A., Cupo, A., Klasse, P.J., et al. Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120. Nat. Struct. Mol. Biol. 20 (2013), 796–803.
23. Kunert, R., Rüker, F., Katinger, H., Molecular characterization of five neutralizing anti-HIV type 1 antibodies: identification of nonconventional D segments in the human monoclonal antibodies 2G12 and 2F5. AIDS Res. Hum. Retroviruses 14 (1998), 1115–1128.
24. Kwon, Y.D., Pancera, M., Acharya, P., Georgiev, I.S., Crooks, E.T., Gorman, J., Joyce, M.G., Guttman, M., Ma, X., Narpala, S., et al. Crystal structure, conformational fixation and entry-related interactions of mature ligand-free HIV-1 Env. Nat. Struct. Mol. Biol. 22 (2015), 522–531.
25. Landais, E., Huang, X., Havenar-Daughton, C., Murrell, B., Price, M.A., Wickramasinghe, L., Ramos, A., Bian, C.B., Simek, M., Allen, S., et al. Broadly neutralizing antibody responses in a large longitudinal sub-saharan HIV primary infection cohort. PLoS Pathog., 12, 2016, e1005369.
26. Lee, J.H., de Val, N., Lyumkis, D., Ward, A.B., Model building and refinement of a natively glycosylated HIV-1 Env protein by high-resolution cryoelectron microscopy. Structure 23 (2015), 1943–1951.
27. Lefranc, M.P., Giudicelli, V., Ginestoux, C., Jabado-Michaloud, J., Folch, G., Bellahcene, F., Wu, Y., Gemrot, E., Brochet, X., Lane, J., et al. IMGT, the international ImMunoGeneTics information system. Nucleic Acids Res. 37 (2009), D1006–D1012.
28. Li, L., Wang, X.H., Williams, C., Volsky, B., Steczko, O., Seaman, M.S., Luthra, K., Nyambi, P., Nadas, A., Giudicelli, V., et al. A broad range of mutations in HIV-1 neutralizing human monoclonal antibodies specific for V2, V3, and the CD4 binding site. Mol. Immunol. 66 (2015), 364–374.
29. Liao, H.X., Lynch, R., Zhou, T., Gao, F., Alam, S.M., Boyd, S.D., Fire, A.Z., Roskin, K.M., Schramm, C.A., Zhang, Z., et al., NISC Comparative Sequencing Program. Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus. Nature 496 (2013), 469–476.
30. Lovelace, E., Xu, H., Blish, C.A., Strong, R., Overbaugh, J., The role of amino acid changes in the human immunodeficiency virus type 1 transmembrane domain in antibody binding and neutralization. Virology 421 (2011), 235–244.
31. Lynch, R.M., Boritz, E., Coates, E.E., DeZure, A., Madden, P., Costner, P., Enama, M.E., Plummer, S., Holman, L., Hendel, C.S., et al., VRC 601 Study Team. Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection. Sci. Transl. Med., 7, 2015, 319ra206.
32. Mascola, J.R., Haynes, B.F., HIV-1 neutralizing antibodies: understanding nature's pathways. Immunol. Rev. 254 (2013), 225–244.
33. Milligan, C., Omenda, M.M., Chohan, V., Odem-Davis, K., Richardson, B.A., Nduati, R., Overbaugh, J., Maternal neutralization-resistant virus variants do not predict infant HIV infection risk. MBio, 7, 2016 e02221–15.
34. Moody, M.A., Yates, N.L., Amos, J.D., Drinker, M.S., Eudailey, J.A., Gurley, T.C., Marshall, D.J., Whitesides, J.F., Chen, X., Foulger, A., et al. HIV-1 gp120 vaccine induces affinity maturation in both new and persistent antibody clonal lineages. J. Virol. 86 (2012), 7496–7507.
35. Mouquet, H., Antibody B cell responses in HIV-1 infection. Trends Immunol. 35 (2014), 549–561.
36. Mouquet, H., Scharf, L., Euler, Z., Liu, Y., Eden, C., Scheid, J.F., Halper-Stromberg, A., Gnanapragasam, P.N., Spencer, D.I., Seaman, M.S., et al. Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies. Proc. Natl. Acad. Sci. USA 109 (2012), E3268–E3277.
37. Nduati, R., John, G., Mbori-Ngacha, D., Richardson, B., Overbaugh, J., Mwatha, A., Ndinya-Achola, J., Bwayo, J., Onyango, F.E., Hughes, J., Kreiss, J., Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial. JAMA 283 (2000), 1167–1174.
38. Ng, C.T., Jaworski, J.P., Jayaraman, P., Sutton, W.F., Delio, P., Kuller, L., Anderson, D., Landucci, G., Richardson, B.A., Burton, D.R., et al. Passive neutralizing antibody controls SHIV viremia and enhances B cell responses in infant macaques. Nat. Med. 16 (2010), 1117–1119.
39. Palmer, S., Kearney, M., Maldarelli, F., Halvas, E.K., Bixby, C.J., Bazmi, H., Rock, D., Falloon, J., Davey, R.T. Jr., Dewar, R.L., et al. Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis. J. Clin. Microbiol. 43 (2005), 406–413.
40. Parren, P.W., Mondor, I., Naniche, D., Ditzel, H.J., Klasse, P.J., Burton, D.R., Sattentau, Q.J., Neutralization of human immunodeficiency virus type 1 by antibody to gp120 is determined primarily by occupancy of sites on the virion irrespective of epitope specificity. J. Virol. 72 (1998), 3512–3519.
41. Pejchal, R., Doores, K.J., Walker, L.M., Khayat, R., Huang, P.S., Wang, S.K., Stanfield, R.L., Julien, J.P., Ramos, A., Crispin, M., et al. A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield. Science 334 (2011), 1097–1103.
42. Pettersen, E.F., Goddard, T.D., Huang, C.C., Couch, G.S., Greenblatt, D.M., Meng, E.C., Ferrin, T.E., UCSF Chimera–a visualization system for exploratory research and analysis. J. Comput. Chem. 25 (2004), 1605–1612.
43. Sanders, R.W., Derking, R., Cupo, A., Julien, J.P., Yasmeen, A., de Val, N., Kim, H.J., Blattner, C., de la Peña, A.T., Korzun, J., et al. A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies. PLoS Pathog., 9, 2013, e1003618.
44. Sanders, R.W., van Gils, M.J., Derking, R., Sok, D., Ketas, T.J., Burger, J.A., Ozorowski, G., Cupo, A., Simonich, C., Goo, L., et al. HIV-1 VACCINES. HIV-1 neutralizing antibodies induced by native-like envelope trimers. Science, 349, 2015, aac4223.
45. Scanlan, C.N., Pantophlet, R., Wormald, M.R., Ollmann Saphire, E., Stanfield, R., Wilson, I.A., Katinger, H., Dwek, R.A., Rudd, P.M., Burton, D.R., The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1–>2 mannose residues on the outer face of gp120. J. Virol. 76 (2002), 7306–7321.
46. Scheid, J.F., Mouquet, H., Ueberheide, B., Diskin, R., Klein, F., Oliveira, T.Y., Pietzsch, J., Fenyo, D., Abadir, A., Velinzon, K., et al. Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding. Science 333 (2011), 1633–1637.
47. Scherer, E.M., Smith, R.A., Simonich, C.A., Niyonzima, N., Carter, J.J., Galloway, D.A., Characteristics of memory B cells elicited by a highly efficacious HPV vaccine in subjects with no pre-existing immunity. PLoS Pathog., 10, 2014, e1004461.
48. Siegrist, C.A., Aspinall, R., B-cell responses to vaccination at the extremes of age. Nat. Rev. Immunol. 9 (2009), 185–194.
49. Sok, D., Laserson, U., Laserson, J., Liu, Y., Vigneault, F., Julien, J.P., Briney, B., Ramos, A., Saye, K.F., Le, K., et al. The effects of somatic hypermutation on neutralization and binding in the PGT121 family of broadly neutralizing HIV antibodies. PLoS Pathog., 9, 2013, e1003754.
50. Tang, G., Peng, L., Baldwin, P.R., Mann, D.S., Jiang, W., Rees, I., Ludtke, S.J., EMAN2: an extensible image processing suite for electron microscopy. J. Struct. Biol. 157 (2007), 38–46.
51. Trkola, A., Purtscher, M., Muster, T., Ballaun, C., Buchacher, A., Sullivan, N., Srinivasan, K., Sodroski, J., Moore, J.P., Katinger, H., Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1. J. Virol. 70 (1996), 1100–1108.
52. Walker, L.M., Huber, M., Doores, K.J., Falkowska, E., Pejchal, R., Julien, J.P., Wang, S.K., Ramos, A., Chan-Hui, P.Y., Moyle, M., et al., Protocol G Principal Investigators. Broad neutralization coverage of HIV by multiple highly potent antibodies. Nature 477 (2011), 466–470.
53. West, A.P. Jr., Scharf, L., Scheid, J.F., Klein, F., Bjorkman, P.J., Nussenzweig, M.C., Structural insights on the role of antibodies in HIV-1 vaccine and therapy. Cell 156 (2014), 633–648.
54. Wibmer, C.K., Moore, P.L., Morris, L., HIV broadly neutralizing antibody targets. Curr. Opin. HIV AIDS 10 (2015), 135–143.
55. Williams, K.L., Cortez, V., Dingens, A.S., Gach, J.S., Rainwater, S., Weis, J.F., Chen, X., Spearman, P., Forthal, D.N., Overbaugh, J., HIV-specific CD4-induced antibodies mediate broad and potent antibody-dependent cellular cytotoxicity activity and are commonly detected in plasma from HIV-infected humans. EBioMedicine 2 (2015), 1464–1477.
56. Wu, X., Parast, A.B., Richardson, B.A., Nduati, R., John-Stewart, G., Mbori-Ngacha, D., Rainwater, S.M., Overbaugh, J., Neutralization escape variants of human immunodeficiency virus type 1 are transmitted from mother to infant. J. Virol. 80 (2006), 835–844.
57. Wu, X., Yang, Z.Y., Li, Y., Hogerkorp, C.M., Schief, W.R., Seaman, M.S., Zhou, T., Schmidt, S.D., Wu, L., Xu, L., et al. Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1. Science 329 (2010), 856–861.
58. Yasmeen, A., Ringe, R., Derking, R., Cupo, A., Julien, J.P., Burton, D.R., Ward, A.B., Wilson, I.A., Sanders, R.W., Moore, J.P., Klasse, P.J., Differential binding of neutralizing and non-neutralizing antibodies to native-like soluble HIV-1 Env trimers, uncleaved Env proteins, and monomeric subunits. Retrovirology, 11, 2014, 41.
59. Yu, L., Guan, Y., Immunologic basis for long HCDR3s in broadly neutralizing antibodies against HIV-1. Front. Immunol., 5, 2014, 250.
60. Zhou, T., Georgiev, I., Wu, X., Yang, Z.Y., Dai, K., Finzi, A., Kwon, Y.D., Scheid, J.F., Shi, W., Xu, L., et al. Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01. Science 329 (2010), 811–817.
61. Zhu, Z., Qin, H.R., Chen, W., Zhao, Q., Shen, X., Schutte, R., Wang, Y., Ofek, G., Streaker, E., Prabakaran, P., et al. Cross-reactive HIV-1-neutralizing human monoclonal antibodies identified from a patient with 2F5-like antibodies. J. Virol. 85 (2011), 11401–11408.